
Consumer healthcare firm Haleon has revealed a surprise dip in revenues for the latest quarter as it was impacted by weaker sales of painkillers.
Shares in the Sensodyne and Voltaren maker were lower in early trading on Thursday as a result.

Consumer healthcare firm Haleon has revealed a surprise dip in revenues for the latest quarter as it was impacted by weaker sales of painkillers.
Shares in the Sensodyne and Voltaren maker were lower in early trading on Thursday as a result.